Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection.

Maazi H, Singh AK, Speak AO, Lombardi V, Lam J, Khoo B, Inn KS, Sharpe AH, Jung JU, Akbari O.

PLoS One. 2013;8(3):e59599. doi: 10.1371/journal.pone.0059599. Epub 2013 Mar 15.

2.

PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.

Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, Freeman GJ, Sharpe AH, Umetsu DT, Dekruyff RH.

Mucosal Immunol. 2010 Jan;3(1):81-91. doi: 10.1038/mi.2009.112. Epub 2009 Sep 9.

3.

Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.

Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, Renneson J, Bialecki E, Pothlichet J, Vendeville C, Barba-Spaeth G, Huerre MR, Faveeuw C, Si-Tahar M, Trottein F.

J Immunol. 2011 May 15;186(10):5590-602. doi: 10.4049/jimmunol.1002348. Epub 2011 Apr 13. Erratum in: J Immunol. 2011 Aug 1;187(3):1515. Barba-Speath, Giovanna [corrected to Barba-Spaeth, Giovanna].

4.

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Paget C, Ivanov S, Fontaine J, Renneson J, Blanc F, Pichavant M, Dumoutier L, Ryffel B, Renauld JC, Gosset P, Gosset P, Si-Tahar M, Faveeuw C, Trottein F.

J Biol Chem. 2012 Mar 16;287(12):8816-29. doi: 10.1074/jbc.M111.304758. Epub 2012 Jan 31.

5.

Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.

Durgan K, Ali M, Warner P, Latchman YE.

Cancer Immunol Immunother. 2011 Apr;60(4):547-58. doi: 10.1007/s00262-010-0963-5. Epub 2011 Jan 15.

6.

Infection with influenza virus induces IL-33 in murine lungs.

Le Goffic R, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, Piquet-Pellorce C, Samson M.

Am J Respir Cell Mol Biol. 2011 Dec;45(6):1125-32. doi: 10.1165/rcmb.2010-0516OC. Epub 2011 Jun 3.

PMID:
21642589
7.

PD-L1-expressing dendritic cells contribute to viral resistance during acute HSV-1 infection.

Bryant-Hudson KM, Carr DJ.

Clin Dev Immunol. 2012;2012:924619. doi: 10.1155/2012/924619. Epub 2012 Feb 28.

8.

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.

Parekh VV, Lalani S, Kim S, Halder R, Azuma M, Yagita H, Kumar V, Wu L, Kaer LV.

J Immunol. 2009 Mar 1;182(5):2816-26. doi: 10.4049/jimmunol.0803648.

9.

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.

De Santo C, Salio M, Masri SH, Lee LY, Dong T, Speak AO, Porubsky S, Booth S, Veerapen N, Besra GS, Gröne HJ, Platt FM, Zambon M, Cerundolo V.

J Clin Invest. 2008 Dec;118(12):4036-48. doi: 10.1172/JCI36264. Epub 2008 Nov 13.

10.

Effect of PD-1: PD-L1 in Invariant Natural Killer T-Cell Emigration and Chemotaxis Following Sepsis.

Young JS, Heffernan DS, Chung CS, Kettenmann ML, Young WA, Guillen VS, Cioffi WG, Ayala A.

Shock. 2016 May;45(5):534-9. doi: 10.1097/SHK.0000000000000553.

11.

Transcriptional analysis of immune-related gene expression in p53-deficient mice with increased susceptibility to influenza A virus infection.

Yan W, Wei J, Deng X, Shi Z, Zhu Z, Shao D, Li B, Wang S, Tong G, Ma Z.

BMC Med Genomics. 2015 Aug 18;8:52. doi: 10.1186/s12920-015-0127-8.

12.

Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection.

Ho LP, Denney L, Luhn K, Teoh D, Clelland C, McMichael AJ.

Eur J Immunol. 2008 Jul;38(7):1913-22. doi: 10.1002/eji.200738017.

13.

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH.

J Exp Med. 2006 Apr 17;203(4):883-95. Epub 2006 Apr 10.

14.

Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.

Saha A, Aoyama K, Taylor PA, Koehn BH, Veenstra RG, Panoskaltsis-Mortari A, Munn DH, Murphy WJ, Azuma M, Yagita H, Fife BT, Sayegh MH, Najafian N, Socie G, Ahmed R, Freeman GJ, Sharpe AH, Blazar BR.

Blood. 2013 Oct 24;122(17):3062-73. doi: 10.1182/blood-2013-05-500801. Epub 2013 Sep 12.

15.

Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production.

Matsuda H, Takeda K, Koya T, Okamoto M, Shiraishi Y, Miyahara N, Dakhama A, Matsuda JL, Gapin L, Gelfand EW.

J Immunol. 2010 Jul 1;185(1):253-62. doi: 10.4049/jimmunol.0902301. Epub 2010 Jun 4.

16.

The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection.

Zhang E, Zhang X, Liu J, Wang B, Tian Y, Kosinska AD, Ma Z, Xu Y, Dittmer U, Roggendorf M, Yang D, Lu M.

PLoS One. 2011;6(10):e26196. doi: 10.1371/journal.pone.0026196. Epub 2011 Oct 14.

17.

PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell response.

Valero-Pacheco N, Arriaga-Pizano L, Ferat-Osorio E, Mora-Velandia LM, Pastelin-Palacios R, Villasís-Keever MÁ, Alpuche-Aranda C, Sánchez-Torres LE, Isibasi A, Bonifaz L, López-Macías C.

Clin Dev Immunol. 2013;2013:989673. doi: 10.1155/2013/989673. Epub 2013 Sep 26.

18.

The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Brincks EL, Gurung P, Langlois RA, Hemann EA, Legge KL, Griffith TS.

J Immunol. 2011 Nov 1;187(9):4581-8. doi: 10.4049/jimmunol.1002241. Epub 2011 Sep 21.

19.

Neuronal programmed cell death-1 ligand expression regulates retinal ganglion cell number in neonatal and adult mice.

Sham CW, Chan AM, Kwong JM, Caprioli J, Nusinowitz S, Chen B, Lee JG, Gandhi NM, Francisco LM, Sharpe AH, Chen L, Braun J, Gordon LK.

J Neuroophthalmol. 2012 Sep;32(3):227-37.

20.

Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection.

Kok WL, Denney L, Benam K, Cole S, Clelland C, McMichael AJ, Ho LP.

J Leukoc Biol. 2012 Mar;91(3):357-68. doi: 10.1189/jlb.0411184. Epub 2011 Oct 14.

PMID:
22003207

Supplemental Content

Support Center